MassDevice28m
HeartBeam has a new CEO ahead of U.S. commercialization
HeartBeam (Nasdaq:BEAT) announced today that it appointed Robert Eno as its new CEO, effective Monday, Oct. 21, 2024.
MassDevice18h
FDA revokes EUA for Cue Health COVID-19 tests
The FDA today issued a notice classifying the recall of Cue Health COVID-19 tests as Class II and revoking the tests' EUA.
MassDevice21h
Boston Scientific warns on some PolarX cryoablation catheters following reports of death
Boston Scientific issued an urgent field safety notice in Europe to notify customers of updates to its PolarX cryoablation ...
MassDevice23h
Cognito Therapeutics has positive data for Alzheimer’s-modifying therapy
Cognito Therapeutics today announced a publication demonstrating structural brain preservation with its Spectris treatment.